Genetic variants of inducible costimulator are associated with allergic asthma susceptibility - 05/02/15
![](/templates/common/images/mail.png)
![](/templates/common/images/mail.png)
These studies were supported by A*STAR/SIgN core funding, and grants SIgN-06-006, SIgN-08-020, and SIgN-10-029 and NMRC/1150/2008, Singapore. The Dutch Asthma GWAS (DAG) was supported by the Netherlands Asthma Foundation grant AF (AF 95.09, AF 98.48, AF 3.2.02.51, and AF 3.2.07.015) and a grant from the University Medical Center Groningen. |
|
Disclosure of potential conflict of interest: B. Lee is employed by the Singapore Immunology Network. A Nardin is employed by, has received research and travel support from, and has a patent pending with the Singapore Immunology Network, Agency for Science and Technology and Research. D. S. Postma has received consultancy fees from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Takeda, and Teva and has received research support and lecture fees from Chiesi. D. Y. Wang has received research support from the Singapore Ministry of Education Academic Research Fund, Singapore Immunology Network, National Medical Research Council (NMRC) (Singapore), and the Agency for Science Technology and Research (A*STAR) (Singapore) and is employed by the National University of Singapore. F. T. Chew has received research support from the Singapore Ministry of Education Academic Research Fund, Singapore Immunology Network, National Medical Research Council (Singapore), and A*STAR (Singapore); has received consultancy fees from Sime Darby Technology Centre; and is employed by the National University of Singapore. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 135 - N° 2
P. 556 - février 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?